Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis65

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis21

Views

Views
December 20251
January 20260
February 20261
March 20261
April 20268
May 20261
June 20269
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands6
Finland1
United Kingdom1
 

Top cities views

Views
Groningen6
Los Angeles2
Helsinki1